Theravance Biopharma, Inc.
DE ˙ DB ˙ KYG8807B1068
13,60 € ↑0,30 (2,26%)
2026-06-04
DEL PRIS
SecurityDE:0TB / Theravance Biopharma, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership70,080 shares
Latest Disclosed Value $ 1,311,197
Alliancebernstein L.p. ownership in 0TB / Theravance Biopharma, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 70,080 shares of Theravance Biopharma, Inc. (DE:0TB) valued at $925,056 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 70,080 shares of Theravance Biopharma, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $953,088 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 70,080 0 0.00 1,311 0.00 0.0004
2026-02-17 2025-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 70,080 0 0.00 1,311 28.15 0.0004
2025-11-14 2025-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 70,080 0 0.00 1,023 32.51 0.0003
2025-08-14 2025-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 70,080 -3,300 -4.50 773 17.86 0.0003
2025-05-15 2025-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 73,380 -3,775 -4.89 655 -9.78 0.0002
2025-02-12 2024-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 77,155 -1,700 -2.16 726 14.33 0.0002
2024-11-14 2024-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 78,855 0 0.00 636 -4.94 0.0002
2024-08-14 2024-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 78,855 6,220 8.56 669 2.61 0.0002
2024-05-14 2024-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 72,635 -5,100 -6.56 652 -25.43 0.0002
2024-02-14 2023-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 77,735 0 0.00 874 30.30 0.0003
2023-11-14 2023-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 77,735 0 0.00 671 -16.67 0.0003
2023-08-15 2023-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 77,735 0 0.00 805 -4.63 0.0003
2023-05-15 2023-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 77,735 0 0.00 843 -3.33 0.0004
2023-02-15 2022-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 77,735 0 0.00 872 10.66 0.0004
2022-11-15 2022-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 77,735 0 0.00 788 11.93 0.0004
2022-08-15 2022-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 77,735 0 0.00 704 -5.25 0.0003
2022-05-13 2022-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 77,735 200 0.26 743 -13.30 0.0003
2022-02-14 2021-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 77,535 6,800 9.61 857 63.86 0.0003
2021-11-10 2021-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 70,735 0 0.00 523 -49.07 0.0002
2021-07-30 2021-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 70,735 0 0.00 1,027 -28.88 0.0004
2021-05-06 2021-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 70,735 -6,000 -7.82 1,444 5.87 0.0006
2021-02-08 2020-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 76,735 0 0.00 1,364 20.18 0.0006
2020-11-12 2020-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 76,735 -1,300 -1.67 1,135 -30.71 0.0006
2020-08-13 2020-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 78,035 13,500 20.92 1,638 9.86 0.0010
2020-05-14 2020-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 64,535 300 0.47 1,491 -10.34 0.0011
2020-02-18 2019-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 64,235 1,300 2.07 1,663 35.64 0.0009
2019-11-14 2019-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 62,935 0 0.00 1,226 19.26 0.0008
2019-08-14 2019-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 62,935 0 0.00 1,028 -27.96 0.0006
2019-05-14 2019-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 62,935 0 0.00 1,427 -11.42 0.0009
2019-02-13 2018-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 62,935 -700 -1.10 1,611 -22.51 0.0012
2018-11-08 2018-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 63,635 1,800 2.91 2,079 48.29 0.0014
2018-08-13 2018-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 61,835 2,200 3.69 1,402 -3.04 0.0010
2018-05-14 2018-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 59,635 -1,600 -2.61 1,446 -15.34 0.0010
2018-02-13 2017-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 61,235 0 0.00 1,708 -18.55 0.0012
2017-11-13 2017-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 61,235 0 0.00 2,097 -14.06 0.0016
2017-08-10 2017-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 61,235 5,100 9.09 2,440 18.05 0.0019
2017-05-11 2017-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 56,135 -1,100 -1.92 2,067 13.26 0.0016
2017-02-13 2016-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 57,235 0 0.00 1,825 -12.01 0.0015
2016-11-10 2016-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 57,235 -604 -1.04 2,074 58.08 0.0018
2016-08-11 2016-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 57,839 25,100 76.67 1,312 113.33 0.0011
2016-05-13 2016-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 32,739 2,300 7.56 615 23.25 0.0005
2016-02-16 2015-12-31 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 30,439 0 0.00 499 48.96 0.0004
2016-02-12 2015-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 30,439 335
2015-11-13 2015-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 30,439 -262,338 -89.60 335 -91.21 0.0003
2015-08-14 2015-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 292,777 112,080 62.03 3,812 21.59 0.0031
2015-05-13 2015-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 180,697 81,527 82.21 3,135 111.82 0.0025
2015-02-13 2014-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 99,170 42,559 75.18 1,480 13.41 0.0012
2014-11-13 2014-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 56,611 -23 -0.04 1,305 -27.70 0.0011
2014-08-13 2014-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 56,634 56,634 1,805 0.0015
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.